AI model can predict high blood pressure and related complications from ECGs

An AI model can be used to predict both the risk of high blood pressure and which patients may go on to experience complications from high blood pressure using an ECG, new research reveals.

© Stux/Pixabay

© Stux/Pixabay

Researchers from Imperial College London and Imperial College Healthcare NHS Trust have used large sets of data, consisting of more than one million ECGs previously taken as part of routine care, to train their AI model to be able to accurately identify which patients went on to develop high blood pressure or related complications.

The team also found that the system could accurately predict which patients went on to experience a stroke, heart attack or even patients who died by simply using a score generated by the AI system that was independent of other clinical risk factors. 

Researchers will be testing the AI technology with NHS patients this year in clinical trials at Imperial College Healthcare NHS Trust hospitals, which are supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre.

Lead researcher, Dr Arunashis Sau, a cardiology specialist registrar and academic clinical lecturer at Imperial College London, said: ‘If we can use AI to identify those patients at highest risk of high blood pressure, we can help motivate patients to make the right lifestyle changes to potentially prevent it from happening.'

The research team have recently demonstrated two other models developed with a similar approach – one which looked at how the model could predict health risks more generally and the other used it to predict the risk of developing diabetes. 

The clinical trials will focus on evaluating the benefits of implementing the model with real patients and will start by mid-2025.

Private hospitals and NHS partner on £10m cardiometabolic programme

Private hospitals and NHS partner on £10m cardiometabolic programme

By Lee Peart 17 November 2026

Private hospitals are partnering with the NHS on a £10m programme designed for the faster roll out of cardiometabolic innovations.

Gaps in lithium monitoring limiting bipolar treatment

By Lee Peart 12 November 2026

Gaps in monitoring systems are limiting the use of lithium as a bipolar treatment, HSSIB has warned.

Health research needs AI governance that can keep pace with innovation

09 November 2026

Michael Measures, healthcare chief technology officer, Kainos, and former technical director at NHSX argues a common, proportionate approach to AI assurance...


Popular articles by Liz Wells